会计年度:2018-12-31收入分布
| 项目名称 | 主营业务收入 | 主营业务成本 | 主营业务毛利 | 毛利率 | ||||
| 保健品 | 241,964,070.71 | 86,892,684.56 | 155,071,386.15 | 64.09 | ||||
| 工业 | 3,735,453,103.30 | 1,693,741,238.00 | 2,041,711,865.30 | 54.66 | ||||
| 工业小计 | 3,735,453,103.30 | 1,693,741,238.00 | 2,041,711,865.30 | 54.66 | ||||
| 合计 | 10,813,613,594.67 | 7,868,216,908.42 | 2,945,396,686.25 | 27.24 | ||||
| 化学原料药 | 144,491,982.69 | 167,930,585.42 | -23,438,602.73 | -16.22 | ||||
| 化学制剂 | 2,539,998,154.20 | 991,488,675.07 | 1,548,509,479.13 | 60.96 | ||||
| 零售 | 1,081,278,453.35 | 786,389,033.42 | 294,889,419.93 | 27.27 | ||||
| 批发商业客户 | 1,105,642,402.60 | 1,061,698,596.37 | 43,943,806.23 | 3.97 | ||||
| 批发医疗客户 | 4,747,464,665.21 | 4,256,988,970.64 | 490,475,694.57 | 10.33 | ||||
| 其他 | 88,145,043.93 | 43,712,767.52 | 44,432,276.41 | 50.41 | ||||
| 其他(补充) | 55,629,926.28 | 25,686,302.46 | 29,943,623.82 | 53.83 | ||||
| 其它 | 16,148,658.59 | 4,244,212.78 | 11,904,445.81 | 73.72 | ||||
| 其中:保健品 | 241,964,070.71 | 86,892,684.56 | 155,071,386.15 | 64.09 | ||||
| 其中:化学原料药 | 144,491,982.69 | 167,930,585.42 | -23,438,602.73 | -16.22 | ||||
| 其中:化学制剂 | 2,539,998,154.20 | 991,488,675.07 | 1,548,509,479.13 | 60.96 | ||||
| 其中:零售 | 1,081,278,453.35 | 786,389,033.42 | 294,889,419.93 | 27.27 | ||||
| 其中:批发商业客户 | 1,105,642,402.60 | 1,061,698,596.37 | 43,943,806.23 | 3.97 | ||||
| 其中:批发医疗客户 | 4,747,464,665.21 | 4,256,988,970.64 | 490,475,694.57 | 10.33 | ||||
| 其中:其他 | 88,145,043.93 | 43,712,767.52 | 44,432,276.41 | 50.41 | ||||
| 其中:其它 | 16,148,658.59 | 4,244,212.78 | 11,904,445.81 | 73.72 | ||||
| 其中:生物制剂 | 99,449,236.83 | 48,024,882.40 | 51,424,354.43 | 51.71 | ||||
| 其中:中药 | 693,401,000.28 | 395,160,197.77 | 298,240,802.51 | 43.01 | ||||
| 商业 | 7,022,530,565.09 | 6,148,789,367.95 | 873,741,197.14 | 12.44 | ||||
| 商业小计 | 7,022,530,565.09 | 6,148,789,367.95 | 873,741,197.14 | 12.44 | ||||
| 生物制剂 | 99,449,236.83 | 48,024,882.40 | 51,424,354.43 | 51.71 | ||||
| 中药 | 693,401,000.28 | 395,160,197.77 | 298,240,802.51 | 43.01 | ||||
会计年度:2018-06-30
| 项目名称 | 主营业务收入 | 主营业务成本 | 主营业务毛利 | 毛利率 | ||||
| 保健品 | 315,512,223.10 | 93,320,849.73 | 222,191,373.37 | 70.42 | ||||
| 合计 | 5,633,933,498.80 | 4,061,772,633.72 | 1,572,160,865.08 | 27.91 | ||||
| 化学原料药 | 95,609,619.99 | 115,639,001.25 | -20,029,381.26 | -20.95 | ||||
| 化学制剂 | 1,221,044,527.83 | 535,761,411.34 | 685,283,116.49 | 56.12 | ||||
| 其他(补充) | 24,071,925.77 | 11,384,407.47 | 12,687,518.30 | 52.71 | ||||
| 其它 | 10,942,282.55 | 4,420,984.97 | 6,521,297.58 | 59.60 | ||||
| 商业小计 | 3,444,434,331.69 | 3,017,961,352.75 | 426,472,978.94 | 12.38 | ||||
| 生物制剂 | 50,989,756.81 | 25,332,578.55 | 25,657,178.26 | 50.32 | ||||
| 中药 | 471,328,831.06 | 257,952,047.66 | 213,376,783.40 | 45.27 | ||||
会计年度:2017-12-31
| 项目名称 | 主营业务收入 | 主营业务成本 | 主营业务毛利 | 毛利率 | ||||
| 保健品 | 409,814,995.26 | 100,341,522.85 | 309,473,472.41 | 75.52 | ||||
| 工业小计 | 3,994,691,111.76 | 1,818,580,305.46 | 2,176,110,806.30 | 54.48 | ||||
| 合计 | 11,978,692,649.31 | 8,895,929,752.79 | 3,082,762,896.52 | 25.74 | ||||
| 化学原料药 | 221,604,593.85 | 231,306,025.32 | -9,701,431.47 | -4.38 | ||||
| 化学制剂 | 2,500,237,489.86 | 1,006,353,849.91 | 1,493,883,639.95 | 59.75 | ||||
| 零售 | 1,162,249,601.72 | 835,698,912.16 | 326,550,689.56 | 28.10 | ||||
| 批发商业客户 | 1,672,677,870.81 | 1,596,366,362.48 | 76,311,508.33 | 4.56 | ||||
| 批发医疗客户 | 5,057,602,091.55 | 4,587,523,791.88 | 470,078,299.67 | 9.29 | ||||
| 其他 | 91,471,973.47 | 57,760,380.81 | 33,711,592.66 | 36.85 | ||||
| 其它 | 16,665,023.46 | 4,061,709.97 | 12,603,313.49 | 75.63 | ||||
| 商业小计 | 7,984,001,537.55 | 7,077,349,447.33 | 906,652,090.22 | 11.36 | ||||
| 生物制剂 | 119,339,657.81 | 50,364,272.98 | 68,975,384.83 | 57.80 | ||||
| 中药 | 727,029,351.52 | 426,152,924.43 | 300,876,427.09 | 41.38 | ||||
会计年度:2017-06-30
| 项目名称 | 主营业务收入 | 主营业务成本 | 主营业务毛利 | 毛利率 | ||||
| 保健品 | 29,371.00 | 7,656.19 | 21,714.81 | 73.93 | ||||
| 化学原料药 | 11,146.69 | 11,250.61 | -103.92 | -0.93 | ||||
| 化学制剂 | 128,501.04 | 54,326.85 | 74,174.19 | 57.72 | ||||
| 其它 | 995.46 | 543.58 | 451.88 | 45.39 | ||||
| 商业 | 399,081.91 | 355,197.41 | 43,884.50 | 11.00 | ||||
| 生物制剂 | 5,883.71 | 2,578.98 | 3,304.73 | 56.17 | ||||
| 中药 | 39,705.25 | 22,131.43 | 17,573.82 | 44.26 | ||||
会计年度:2016-12-31
| 项目名称 | 主营业务收入 | 主营业务成本 | 主营业务毛利 | 毛利率 | ||||
| 保健品 | 668,882,195.83 | 163,425,061.19 | 505,457,134.64 | 75.57 | ||||
| 化学原料药 | 330,168,587.41 | 350,782,208.41 | -20,613,621.00 | -6.24 | ||||
| 化学制剂 | 2,955,778,288.26 | 1,135,936,025.40 | 1,819,842,262.86 | 61.57 | ||||
| 零售 | 1,151,868,346.10 | 826,137,533.96 | 325,730,812.14 | 28.28 | ||||
| 批发商业客户 | 2,543,500,713.34 | 2,414,380,829.87 | 129,119,883.47 | 5.08 | ||||
| 批发医疗客户 | 5,205,536,060.35 | 4,807,454,116.22 | 398,081,944.13 | 7.65 | ||||
| 其他 | 81,481,501.32 | 54,095,206.55 | 27,386,294.77 | 33.61 | ||||
| 其它 | 59,965,421.79 | 21,443,990.69 | 38,521,431.10 | 64.24 | ||||
| 商业小计 | 8,982,386,621.11 | 8,102,067,686.60 | 880,318,934.51 | 9.80 | ||||
| 生物制剂 | 161,553,369.92 | 62,228,181.66 | 99,325,188.26 | 61.48 | ||||
| 中药 | 925,283,063.48 | 538,639,324.75 | 386,643,738.73 | 41.79 | ||||
2/9 转到 
违法和不良信息举报电话：010-85650899 传真：010-85650844 邮箱：yhts@staff.hexun.com
Copyright©和讯网 北京和讯在线信息咨询服务有限公司 All Rights Reserved 版权所有 复制必究 京ICP备10021077号
Copyright©和讯网 北京和讯在线信息咨询服务有限公司 All Rights Reserved 版权所有 复制必究 京ICP备10021077号